Vitamin K deficiency bleeding: the readiness is aU

Clarke, Paul; Shearer, Martin J.
September 2007
Archives of Disease in Childhood;Sep2007, Vol. 92 Issue 9, p741
Academic Journal
The authors reflect on the association between neonatal bleeding disorder and vitamin K deficiency in Great Britain. They mention the publication of the article "Haemorrhagic disease of the newborn returns," triggering the rediscovery of deficiency syndrome and accurately termed vitamin K deficiency bleeding (VKDB). They discuss the publication of the 2003 survey on prophylaxis in the region.


Related Articles

  • Delayed haemorrhagic disease of the newborn with extradural haematoma. Cooper, N.A.; Lynch, M.A. // British Medical Journal;1/20/1979, Vol. 1 Issue 6157, p164 

    Focuses on the increase risk of hemorrhagic disorders associated with vitamin K deficiency. Role of breast-feeding etiology; Signs and symptoms of vitamin K deficiency; Discussions on acute neurological complications.

  • Vitamin K Deficiency Disease. Innis, Michael D. // Journal of Orthomolecular Medicine;2008 1st Quarter, Vol. 23 Issue 1, p15 

    Vitamin K deficiency bleeding (VKDB) previously known as hemorrhagic disease of the newborn has been classified as Early (0-24hrs), Classic (2-7 days) and Late (1-6 months). Child birth following the maternal ingestion of anti-epileptic drugs such as Phenytoin, is liable to result in early VKDB...

  • Vitamin K deficiency bleeding in Great Britain and Ireland: British Paediatric Surveillance Unit Surveys, 1993–94 and 2001–02. McNinch, Andrew; Busfield, Alison; Tripp, John // Archives of Disease in Childhood;Sep2007, Vol. 92 Issue 9, p759 

    Objective: To conduct and report monitoring of vitamin K deficiency bleeding (VKDB) in Great Britain and Ireland following the 1988–90 survey (VKDB-90). Design: Two 2-year surveys conducted during 1993–4 (VKDB-94) and 2001–02 (VKDB-02). Setting: Data collected from all...

  • Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness. Busfield, Alison; McNinch, Andrew; Tripp, John // Archives of Disease in Childhood;Sep2007, Vol. 92 Issue 9, p754 

    Objective: To determine current use of vitamin K (VK) prophylaxis in newborns and review the efficacy and effectiveness of regimens used. Design: Efficacy and effectiveness calculated using current practice details, data from Southern Ireland and two previous surveys, together with...

  • Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom. Handel, Jeffrey; Tripp, John H. // BMJ: British Medical Journal (International Edition);11/2/91, Vol. 303 Issue 6810, p1109 

    Examines he oral administration of vitamin K prophylaxis on the neonates to protect against hemorrhagic disease of the newborn in Great Britain. Association between the use of vitamin K and kernicterus in premature babies; Costs of treating the babies; Influence of the oral vitamin on the low...

  • Dependant factors. Jones, D // British Dental Journal;2/26/2005, Vol. 198 Issue 4, p217 

    Presents a letter to the editor responding to another letter published a 2004 issue of the "British Dental Journal," detailing hemorrhagic tendencies and the role of Vitamin K in the coagulation pathway.

  • Baby Steps Backward. Mangu-Ward, Katherine // Reason;Nov2014, Vol. 46 Issue 6, p11 

    The article presents information related to Vitamin K deficiency bleeding (VKDB), which is a very rare condition in the U.S.

  • Late Vitamin K Deficiency Bleeding in Infants Whose Parents Declined Vitamin K Prophylaxis - Tennessee, 2013. Warren, Michael; Miller, Angela; Traylor, Julie; Sidonio, Robert; Morad, Anna; Goodman, Alyson; Christensen, Deborah; Grant, Althea; Odom, Erika; Okoroh, Ekwutosi; Clayton, Joshua; Maenner, Matthew; Marcewicz, Lauren // MMWR Recommendations & Reports;11/15/2013, Vol. 62 Issue 45, p901 

    The article focuses on the vitamin K deficiency bleeding (VKDB) in infants who do not have sufficient vitamin K stores for the production of clotting factors. It highlights the diagnosis of K deficient bleeding at a children's hospital in Nashville, Tennessee from February to September 2013. It...

  • Fixed-dose PCC better option for VKA emergency reversal.  // Reactions Weekly;5/18/2013, Issue 1453, p3 

    The article reports on the results of a study by researchers from the Netherlands which revealed that a low fixed dose of prothrombin complex concentrate for reversal emergency bleeding linked with vitamin K antagonist therapy is more cost effective compared with a high variable dosing strategy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics